Galaxy Medicare Limited has confirmed to the National Stock Exchange of India that its promoters and promoter group hold no encumbrance on their shares for the financial year ended March 31, 2026. The disclosure, submitted on April 7, 2026, complies with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which requires annual declarations regarding the status of shareholding by key stakeholders.

The filing includes a formal declaration from Subhasish Das on behalf of all promoters and the promoter group. It explicitly states that no encumbrance was created directly or indirectly on the shares held by them during FY26. Furthermore, the promoters confirmed that as of March 31, 2026, none of the company's shares held by the group were encumbered, invoked, or pledged.

The disclosure covers 15 entities, comprising individual promoters, Hindu Undivided Families (HUFs), and corporate entities within the promoter group. The comprehensive list ensures transparency regarding the shareholding status of the company's key stakeholders.

Promoter and Promoter Group Status

The following table details the entities included in the declaration and their respective encumbrance status:

The submission was signed by Company Secretary Pralaaju Naik and addressed to the Listing Compliance Department of the exchange. The confirmation of unencumbered shares provides assurance to investors regarding the financial stability and lack of leveraging against the promoter's equity in the company.

Galaxy Medicare Limited reported a net profit of ₹341.81 lakh for the financial year ended March 31, 2026, compared to ₹337.05 lakh in the previous year. Revenue from operations for FY26 stood at ₹4,000.33 lakh, a marginal increase from ₹3,920.16 lakh in FY25. The board of directors, meeting on May 29, 2026, approved the audited financial results and recommended a final dividend of ₹0.35 per equity share of face value ₹10 each, subject to shareholder approval at the 34th Annual General Meeting.

The statutory auditors, M/s. A. K. Sabat & Co., issued an unmodified opinion on the audited financial results. However, the auditors drew attention to a matter regarding an advance payment of ₹50 lakh made to the Book Running Lead Manager (BRLM) for the IPO before receipt of proceeds, which was not adjusted by the BRLM while recovering fees. The amount is currently treated as "Advance recoverable" under short-term loans and advances.

Financial Performance

The company's total income for FY26 rose to ₹4,131.53 lakh from ₹4,026.82 lakh in the previous year. Total expenditure increased to ₹3,660.85 lakh from ₹3,573.46 lakh. Earnings per share (basic and diluted) for FY26 were reported at ₹2.25, compared to ₹2.84 in the previous year.

Governance and Appointments

Based on the recommendations of the Nomination & Remuneration Committee, the board approved the re-appointment of Mr. Dillip Kumar Das as Managing Director for a term of two years effective from July 1, 2026, and Mr. Subhasish Das as Whole Time Director for a term of five years effective from August 1, 2026. Additionally, Mr. Shaswat Kumar Rout, Mr. Soumya Mohanty, and Mr. Aklant Das were re-appointed as Independent Directors for a second term of five years effective from April 24, 2026, and September 30, 2026, respectively. All appointments are subject to shareholder approval.

The board also re-appointed M/s. Saroj Ray & Associates, Practicing Company Secretaries, as the Secretarial Auditor for FY27. The company confirmed there were no deviations in the utilization of IPO proceeds during the half-year and year ended March 31, 2026.